Dynamic multidrug therapies for HIV: A control theoretic approach

被引:79
作者
Wein, LM
Zenios, SA
Nowak, MA
机构
[1] STANFORD UNIV, GRAD SCH BUSINESS, STANFORD, CA 94305 USA
[2] UNIV OXFORD, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND
基金
英国工程与自然科学研究理事会; 美国国家科学基金会; 英国惠康基金;
关键词
D O I
10.1006/jtbi.1996.0253
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Motivated by the inability of current drug treatment to provide long-term. benefit to HIV-infected individuals, we derive HIV therapeutic strategies by formulating and analyzing a mathematical control problem. The model tracks the dynamics of uninfected and infected CD4(+) cells and free plasma virus, and allows the virus to mutate into various strains. At each point in time, several different therapeutic options are available, where each option corresponds to a combination of reverse transcriptase inhibitors. The controller observes the individual's current status and chooses among the therapeutic options in a dynamic fashion in order to minimize the total viral load. Our initial numerical results suggest that dynamic therapies have the potential to significantly outperform the static protocols that are currently in use; by anticipating and responding to the disease progression, the dynamic strategy reduces the total free virus, increases the uninfected CD4(+) count, and delays the emergence of drug-resistant strains. (C) 1997 Academic Press Limited.
引用
收藏
页码:15 / 29
页数:15
相关论文
共 44 条
[1]  
AGUR Z, 1989, BIOMEDICAL MODELING, P59
[2]   DYNAMIC PROGRAMMING [J].
BELLMAN, R .
SCIENCE, 1966, 153 (3731) :34-&
[3]  
CARRIER GF, 1991, PARTIAL DIFFERENTIAL
[4]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[5]   Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine [J].
deJong, MD ;
Veenstra, J ;
Stilianakis, NI ;
Schuurman, R ;
Lange, JMA ;
deBoer, RJ ;
Boucher, CAB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5501-5506
[6]  
Elliott RJ, 1994, HIDDEN MARKOV MODELS
[7]   ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED TISSUES BY AMPLIFICATION AND INSITU HYBRIDIZATION REVEALS LATENT AND PERMISSIVE INFECTIONS AT SINGLE-CELL RESOLUTION [J].
EMBRETSON, J ;
ZUPANCIC, M ;
BENEKE, J ;
TILL, M ;
WOLINSKY, S ;
RIBAS, JL ;
BURKE, A ;
HAASE, AT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :357-361
[8]   TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].
ERON, JJ ;
BENOIT, SL ;
JEMSEK, J ;
MACARTHUR, RD ;
SANTANA, J ;
QUINN, JB ;
KURITZKES, DR ;
FALLON, MA ;
RUBIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669
[9]   QUASI-SPECIES DYNAMICS AND THE EMERGENCE OF DRUG-RESISTANCE DURING ZIDOVUDINE THERAPY OF HIV-INFECTION [J].
FROST, SDW ;
MCLEAN, AR .
AIDS, 1994, 8 (03) :323-332
[10]  
Gittins J. C., 1989, Multi -armed bandit allocation indices.